Evotec SE (MIL:1EVT)
€ 8.345 0 (0%) Market Cap: 1.52 Bil Enterprise Value: 1.61 Bil PE Ratio: 0 PB Ratio: 1.56 GF Score: 54/100

Q1 2021 Evotec SE Earnings Call Transcript

May 11, 2021 / 12:00PM GMT
Operator

Dear ladies and gentlemen, welcome to the conference call of Evotec SE. At our customer's request, this conference will be recorded. (Operator Instructions)

May I now hand you over to Werner Lanthaler, CEO, who will lead you through this conference. Please go ahead.

Werner Lanthaler
Evotec SE - CEO & Member of Management Board

Good afternoon. Good morning. Welcome to our Q1 reporting. It's a pleasure to have you on the phone, and it's a pleasure to guide you through our presentation acceleration on The data-driven Autobahn to Cures.

When you go to this presentation, which we have uploaded on the web, and you go to Page #2, let me warmly welcome you. And given the fact that we just recently held a Capital Markets Day on April 20, we also want to invite you to look at this presentation, which is also uploaded. At our Capital Markets Day, we presented extensively a deeper look into our drug discovery platforms and technology. This is why today, we will focus more on our ongoing business and our strong outlook for our midterm view of -- and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot